Media Availability: FDA Announces New Era of Smarter Food Safety, Issues Blueprint
SILVER SPRING, Md., July 13, 2020 /PRNewswire/ --
** FOR CREDENTIALED MEDIA ONLY **
WHAT:
A media availability to discuss the next milestone in the FDA's New Era of Smarter Food Safety Initiative.
WHO:
Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response
Judy McMeekin, Pharm.D., FDA Office of Regulatory Affairs Associate Commissioner
Susan Mayne, Ph.D., FDA Center for Food Safety and Applied Nutrition Director
Steven Solomon, D.V.M., FDA Center for Veterinary Medicine Director
WHEN:
Monday, July 13, 2 p.m. ET
HOW:
Callers in the U.S. or Canada may call 888-989-4351. International callers will need to dial 210-234-0353. The passcode for all callers is "FDA." A replay will be available beginning one hour after the briefing until July 16. To listen to the replay, call 800-964-4586. International callers dial 402-998-0980.
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
Wego, the largest online travel marketplace in the Middle East and North Africa (MENA), is thrilled to announce its continued partnership with the Tourism Authority of Thailand (TAT) for the fourth consecutive year, showcasing the unparalleled beauty...
ENOC Group, a leading integrated global energy player, has appointed the innovative technology loyalty partner, Loyyal, to integrate Access Point, their self-service platform, into the Group's rewards programme. This move will revolutionize the 'YES'...
Systal Technology Solutions, a global managed network, cloud, and security transformation specialist, today announces the opening of its new Network Operations Center (NOC) in Tampa, Florida. This marks the latest milestone in Systal's recent growth...
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...
ATTOM, a leading curator of land, property, and real estate data, today released its first-quarter 2024 U.S. Home Sales Report, which shows that profit margins on median-priced single-family home and condo sales in the United States decreased to 55.3...